(HealthDay)—An Eastern Cooperative Oncology Group (ECOG) performance status of ≥2 is linked to lower treatment satisfaction in patients with relapsed or refractory multiple myeloma (RRMM), but receiving medication orally ...
Aug 20, 2019
0
4
Anxiety is more than twice as common in younger stroke survivors, especially those who show symptoms of depression, than in older patients, according to a new study that recommends routine mental health screenings for survivors ...
Aug 13, 2019
0
51
Adolescent and young adult women with pelvic inflammatory disease (PID) are more likely to experience decreases in Neisseria gonorrhoeae and Chlamydia trachomatis positivity with a technology-enhanced community health nursing ...
Aug 8, 2019
0
0
A new report looks at cancer in adults 85 and older and finds incidence and mortality trends are generally similar to those in people 65 to 84, but screening is unexpectedly high and survival is poorer. The report appears ...
Aug 7, 2019
0
8
Removing the barriers of access to technology does not close the digital divide for African American and older patients, according to new research from The Ohio State University College of Medicine.
Jul 16, 2019
0
0
(HealthDay)—Early prophylactic placement of a vena cava filter compared with no placement of a filter after major trauma does not result in a reduced incidence of symptomatic pulmonary embolism or death at 90 days, according ...
Jul 11, 2019
0
0
Testing new pharmaceutical treatments is a complicated process. Very often, participants have preferences or hopes, either about what the test should measure or about what the outcome should be. Patients often enrol in the ...
Jun 18, 2019
0
1
A pair of studies have found that Obamacare led to an increase in early-stage ovarian cancer detections and helped nearly erase racial differences in the timely treatment of a range of cancers.
Jun 3, 2019
0
19
Glyphosate, the primary ingredient in Monsanto's popular weed killer Roundup, has been linked to liver disease in animal models. In a new study, the first of its kind, researchers at the University of California San Diego ...
May 14, 2019
2
4410
(HealthDay)—Ruzurgi (amifampridine) tablets are now approved to treat Lambert-Eaton myasthenic syndrome (LEMS) in children aged 6 to 17 years, the U.S. Food and Drug Administration announced yesterday.
May 8, 2019
0
0
